NMC Healthcare Partners with TriNetX to Expand Clinical Research and Data Access
NMC Healthcare has made an announcement about their joining the global TriNetX research network to support their expanding academic and clinical research program. Ultimately, this step is to strengthen the NMC research department by enabling its staff to have access to real-world healthcare data as well as to get opportunities for clinical trials worldwide.
The collaboration between NMC and TriNetX is in line with the former s commitment to the advancement of medical research and innovations. NMC has been very active in research as it signaled by the over 200 research applications submitted as well as 140+ papers published in 2020. With this platform, NMC is ready to meet its research demands with not only more formalized engagements but also wider access to the data sources.
TriNetX network includes more than 200 healthcare organizations across the globe that regularly share anonymous clinical data with them. The participating healthcare providers and research teams are able to identify new research trends, draft studies, and find patient populations that fall under their research areas through this platform. Various institutions have been utilizing it to both hasten clinical trial planning and ensure collaboration with sponsors and research teammates in different locations through them.
For NMC Healthcare, allowing them access to this information means the clinical researchers will be able to collaborate on larger and diverse patient datasets. This is important because a broader data set will assist in discovering trends and insights that may not be quite so obvious in small, local data sets. At the same time, TriNetX is also very stringent about privacy and security. The patient confidentiality is kept intact, but the data that has been de-identified is made available for research purposes.
Top management at NMC sees the deal with this network as one of the milestones in expanding the organization s research agenda. NMC has a great desire to benefit from TriNetX’s worldwide network and thus increase its sponsored trials and the volume of its research output. Besides, the company is certain that this platform will enable medical practitioners and researchers to delve into new questions and progress research at a faster pace.
TriNetX had a massive growth during the years. Its network is now extended to many healthcare organizations in different countries that all share de-identified clinical data and collaborate to push research forward. The platform is used by healthcare providers, and life sciences companies to improve processes from trial feasibility and site selection to patient recruitment and real-world evidence generation.
As for NMC’s patients, the cooperation might be converted into more opportunities for them to be part of state-of-the-art clinical trials and thus access to novel therapies. Using real-world data, researchers become able to spot patterns and hints in treatment outcomes, which eventually may lead to the fast implementation of effective care strategies.
NMC Healthcare is a large network of medical facilities, and it has gradually been increasing its research footprint. Being a part of an international data network such as TriNetX is an ambition that the organization is fulfilling, and through it, they are putting themselves in a position with other key healthcare institutions that are also evidence-driven in their approach to advancements in medicine.
In the future, the research teams at NMC will have at their disposal the TriNetX resources to help them conceive studies that mirror genuine patient groups, benchmark results from various regions, and speed up the emergence of new treatments, maybe. This initiative demonstrates NMC’s plan to intensify research strategies and work in concert with other global partners.